2019 annual financial data
Alaunos Therapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -57,858,000 USD and net income was -117,796,000 USD.
Operating cash flow was -40,854,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -57,858,000 USD
- Net income
- -117,796,000 USD
- Operating cash flow
- -40,854,000 USD